SMC approves Xermelo for carcinoid syndrome diarrhoea
13 June 2018 | By European Pharmaceutical Review
Scotland is the first country in the UK to enable patients, battling this serious and debilitating condition, access to a new treatment option...
List view / Grid view
Anti-Cancer Therapeutics
FDA accepts Larotrectinib New Drug Application and Grants Priority Review
31 May 2018 | By European Pharmaceutical Review
The FDA has accepted the NDA and granted Priority Review for larotrectinib for advanced or metastatic solid tumours harbouring a NTRK gene fusion...
DNA-based vaccine treatment for colorectal cancer to undergo first human study
24 May 2018 | By European Pharmaceutical Review
Researchers hope immunotherapy will prevent against overactive immune response...
Anticancer drug nintedanib found to be effective against malignant pleural mesothelioma
18 May 2018 | By European Pharmaceutical Review
Researchers have found that nintedanib shows promising effectiveness in halting the growth of human malignant pleural mesothelioma in preclinical models.
PET scan tracer predicts success of cancer vaccine
15 May 2018 | By European Pharmaceutical Review
By engineering a special molecule to track certain immune cells in the body, scientists have invented a litmus test for the effectiveness of a newly devised cancer therapy...
Cancer drug helps treat tuberculosis by restoring leaky blood vessels
1 May 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Drug that strengthens blood vessels allows antibiotics to infiltrate tuberculosis granulomas in mice...
Cone beam CT offers detailed imaging for precise RS delivery
25 April 2018 | By European Pharmaceutical Review
A novel technique called radiation segmentectomy (RS), that delivers high doses of radiation to tumours while sparing the surrounding healthy tissue, shows promise as a curative treatment option for patients with early-stage liver cancer, according to a recent study.
Vitamin A derivative selectively kills liver cancer stem cells
25 April 2018 | By European Pharmaceutical Review
Acyclic retinoid, an artificial compound derived from vitamin A, has been found to prevent the recurrence of hepatocellular carcinoma...
Combining drugs that target BRAF and HSP90 shows success for melanoma patients
24 April 2018 | By European Pharmaceutical Review
Scientists have tried combining drugs in an effort to prevent resistance development that eventually leads to cancer regrowth in melanoma patients.
Improved method of delivering anti-cancer drugs
20 April 2018 | By European Pharmaceutical Review
A new non-toxic method for delivering anti-cancer drugs to specific parts of the human body could mean the end of the severe side effects...
Two-drug combination proves effective for most lung cancers
6 April 2018 | By European Pharmaceutical Review
New study suggests that using a two-drug combination of currently available treatment could be more effective for most lung cancers.
Combination immunotherapy improves survival in mouse models of mesothelioma
4 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Combined treatment with two cancer immunotherapy drugs significantly prolonged survival in aggressive cancer malignant mesothelioma...
Ionising radiation found to soften tumour cell microenvironment
4 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
When irradiated, less stiff extracellular matrices reduced cancer growth and migration, bolstering the case to further understand fractionated radiation therapy...
Acoustic Cluster Therapy drives drug therapies to cancer cells
21 March 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Researchers are testing the use of pulsed sound waves to direct and focus cancer drug therapies...
Antibiotics may impact cancer treatment efficacy
6 March 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Improper use of antibiotics may have an unintended consequence of hampering cancer treatments...
Follow: